Objectives: To provide lay information about genetics and sickle cell disease (SCD) and to identify and address ethical issues concerning the Sickle Cell Disease Genomics of Africa Network covering autonomy and research decision-making, risk of SCD complications and organ damage, returning of genomic findings, biorepository, data sharing, and healthcare provision for patients with SCD.
Design: Focus groups using qualitative methods.
Setting: Six cities in Ghana, Nigeria and Tanzania within communities and secondary care.
Participants: Patients, parents/caregivers, healthcare professionals, community leaders and government healthcare representatives.
Results: Results from 112 participants revealed similar sensitivities and aspirations around genomic research, an inclination towards autonomous decision-making for research, concerns about biobanking, anonymity in data sharing, and a preference for receiving individual genomic results. Furthermore, inadequate healthcare for patients with SCD was emphasised.
Conclusions: Our findings revealed the eagerness of patients and parents/caregivers to participate in genomics research in Africa, with advice from community leaders and reassurance from health professionals and policy-makers, despite their apprehensions regarding healthcare systems.
Keywords: haematology; medical ethics; public health; qualitative research.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.